The MacDQoL individualized measure of the impact of macular degeneration on quality of life: reliability and responsiveness.

PURPOSE To investigate the MacDQoL test-retest reliability and sensitivity to change in vision over a period of one year in a sample of patients with age-related macular degeneration (AMD). DESIGN A prospective, observational study. METHOD Patients with AMD from an ophthalmologist's list (n = 135) completed the MacDQoL questionnaire by telephone interview and underwent a vision assessment on two occasions, one year apart. RESULTS Among participants whose vision was stable over one year (n = 87), MacDQoL scores at baseline and follow-up were highly correlated (r = 0.95; P < .0001). Twelve of the 22 scale items had intraclass correlations of >.80; only two were correlated <.7. There was no difference between baseline and follow-up scores (P = .85), indicating excellent test-retest reliability. Poorer quality of life (QoL) at follow-up, measured by the MacDQoL present QoL overview item, was associated with deterioration in both the better eye and binocular distance visual acuity [VA] (r = 0.29; P = .001, r = 0.21; P = .016, respectively; n = 135). There was a positive correlation between deterioration in the MacDQoL average weighted impact score and deterioration in both binocular near VA and reading speed (r = 0.20; P = .019, r = 0.18; P = .041, respectively; n = 135). CONCLUSION The MacDQoL has excellent test-retest reliability. Its sensitivity to change in vision status was demonstrated in correlational analyses. The measure indicates that the negative impact of AMD on QoL increases with increasing severity of visual impairment.

[1]  S J Anderson,et al.  Perceived quality of health care in macular disease: a survey of members of the Macular Disease Society , 2002, The British journal of ophthalmology.

[2]  Denis G. Pelli,et al.  THE DESIGN OF A NEW LETTER CHART FOR MEASURING CONTRAST SENSITIVITY , 1988 .

[3]  D A Atchison,et al.  Quantitative Scoring Methods for D15 Panel Tests in the Diagnosis of Congenital Color Vision Deficiencies , 1991, Optometry and vision science : official publication of the American Academy of Optometry.

[4]  Stuart I. Brown,et al.  The psychosocial impact of macular degeneration. , 1998, Archives of ophthalmology.

[5]  S. Anderson,et al.  +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life , 2005, Health and quality of life outcomes.

[6]  P. Kaiser,et al.  Ranibizumab for the treatment of neovascular AMD , 2007, International journal of clinical practice.

[7]  DIFFERENCE BETWEEN OPHTHALMOLOGISTS' AND PATIENTS' PERCEPTIONS OF QUALITY OF LIFE ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION , 2000 .

[8]  K Bandeen-Roche,et al.  Functional status and quality of life measurement among ophthalmic patients. , 1994, Archives of ophthalmology.

[9]  I L Bailey,et al.  Clinical grading and the effects of scaling. , 1991, Investigative ophthalmology & visual science.

[10]  C. Bradley,et al.  14 The MacDQOL Individualized Measure of the Impact of Macular Disease on Quality of Life , 2010 .

[11]  C. Bradley,et al.  Importance of differentiating health status from quality of life , 2001, The Lancet.

[12]  A. Fletcher,et al.  Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. , 2004, Ophthalmology.

[13]  Usha Chakravarthy,et al.  Age related macular degeneration , 2003, BMJ : British Medical Journal.

[14]  F. Eperjesi,et al.  Reliability, normative data, and the effect of age‐related macular disease on the Eger Macular Stressometer photostress recovery time , 2004, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[15]  F. Ferris,et al.  New visual acuity charts for clinical research. , 1982, American journal of ophthalmology.

[16]  R. Wormald,et al.  Is the incidence of registrable age-related macular degeneration increasing? , 1996, The British journal of ophthalmology.

[17]  Clare Bradley,et al.  Design of an Individualised Measure of the Impact of Macular Disease on Quality of Life (the MacDQoL) , 2004, Quality of Life Research.

[18]  M. Larsen,et al.  Interferon alpha‐2a treatment of patients with subfoveal neovascular macular degeneration , 1993, Acta ophthalmologica.

[19]  D. Verma,et al.  Age related macular degeneration: Authors' reply , 2003, BMJ : British Medical Journal.

[20]  C. Terwee,et al.  Psychometric properties of vision‐related quality of life questionnaires: a systematic review , 2004, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[21]  C. McGarty,et al.  Research Methods and Statistics in Psychology , 2003 .

[22]  Gordon E. Legge,et al.  Printed cards for measuring low-vision reading speed , 1995, Vision Research.